相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of ferroptosis in melanoma
Ronan Talty et al.
PIGMENT CELL & MELANOMA RESEARCH (2022)
Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC)
Yeseul Kim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Stress relief for cancer immunotherapy: implications for the ER stress response in tumor immunity
Alex M. Andrews et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Current cancer therapies and their influence on glucose control
Carly Yim et al.
WORLD JOURNAL OF DIABETES (2021)
The Role of Non-essential Amino Acids in T Cell Function and Anti-tumour Immunity
Helen Carrasco Hope et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2021)
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy
Adeleye Oluwatosin Adeshakin et al.
CELLULAR IMMUNOLOGY (2021)
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade
Gladys Ferrere et al.
JCI INSIGHT (2021)
Metabolic reprogramming in macrophage responses
Yang Liu et al.
BIOMARKER RESEARCH (2021)
Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy
Erwan Eriau et al.
CANCERS (2021)
The PD-L1 metabolic interactome intersects with choline metabolism and inflammation
Jesus Pacheco-Torres et al.
CANCER & METABOLISM (2021)
Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor Immunotherapy
Marco Gargaro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Next generation of immune checkpoint inhibitors and beyond
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Energy status dictates PD-L1 protein abundance and anti-tumor to enable blockade
Xiaoming Dai et al.
MOLECULAR CELL (2021)
The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era
Nikolaos Spyrou et al.
SEMINARS IN CANCER BIOLOGY (2021)
IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation
Adaobi Amobi-McCloud et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer
Ajeeth K. Pingili et al.
CELL REPORTS (2021)
Enhancing Checkpoint Inhibitor Therapy in Solid Tissue Cancers: The Role of Diet, the Microbiome & Microbiome-Derived Metabolites
Agnieszka Beata Malczewski et al.
FRONTIERS IN IMMUNOLOGY (2021)
Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1
Hao Cai et al.
FRONTIERS IN IMMUNOLOGY (2021)
Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects
Ratna Veeramachaneni et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
Yousef Zakharia et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Combination Strategies to Augment Immune Check Point Inhibitors Efficacy-Implications for Translational Research
Hrishi Varayathu et al.
FRONTIERS IN ONCOLOGY (2021)
The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Yongchao Zhang et al.
ONCOIMMUNOLOGY (2021)
Th1, Th2, and Th17 cytokines in systemic lupus erythematosus
Farhana Muhammad Yusoff et al.
AUTOIMMUNITY (2020)
Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line
Giorgia Cioccoloni et al.
JOURNAL OF CHEMOTHERAPY (2020)
Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer
Guofeng Ma et al.
MOLECULAR CANCER RESEARCH (2020)
Endoplasmic Reticulum Stress Pathway, the Unfolded Protein Response, Modulates Immune Function in the Tumor Microenvironment to Impact Tumor Progression and Therapeutic Response
Manuel U. Ramirez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancer
Sebastian Yu et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2020)
Metabolomics in multiple sclerosis disease course and progression
Pavan Bhargava et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Fatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma
Run Lin et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications
Katarzyna Zorena et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist GSK3359609 (GSK609) with platinum+5-FU chemotherapy (5-FU/plat), with or without pembrolizumab (PE), for the treatment of advanced solid tumors.
Erminia Massarelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy
Xiaodong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
Clelia Coutzac et al.
NATURE COMMUNICATIONS (2020)
Manipulation of Metabolic Pathways and Its Consequences for Anti-Tumor Immunity: A Clinical Perspective
Huang-Yu Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
Junwei Hou et al.
NATURE CELL BIOLOGY (2020)
Disturbed mitochondrial dynamics in CD8+TILs reinforce T cell exhaustion
Yi-Ru Yu et al.
NATURE IMMUNOLOGY (2020)
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Thomas Powles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Succination inactivates gasdermin D and blocks pyroptosis
Fiachra Humphries et al.
SCIENCE (2020)
The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
Zhi Peng et al.
CANCER IMMUNOLOGY RESEARCH (2020)
The Role of GITR/GITRL Interaction in Autoimmune Diseases
Jie Tian et al.
FRONTIERS IN IMMUNOLOGY (2020)
CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation
Kathryn E. Beckermann et al.
JCI INSIGHT (2020)
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
Yueping Jin et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
Acetate Promotes T Cell Effector Function during Glucose Restriction
Jing Qiu et al.
CELL REPORTS (2019)
Caloric restriction promotes the stemness and antitumor activity of T lymphocytes
Federico Pietrocola et al.
ONCOIMMUNOLOGY (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Metabolomic adaptations and correlates of survival to immune checkpoint blockade
Haoxin Li et al.
NATURE COMMUNICATIONS (2019)
Metabolic Consequences of T-cell Costimulation in Anticancer Immunity
Alvaro Teijeira et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages
Di Lu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis
Brian W. Labadie et al.
CLINICAL CANCER RESEARCH (2019)
Endoplasmic Reticulum Stress Contributes to Mitochondrial Exhaustion of CD8+ T Cells
Katie E. Hurst et al.
CANCER IMMUNOLOGY RESEARCH (2019)
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis
Inaki Etxeberria et al.
ESMO OPEN (2019)
Targeted Metabolomic Analysis of Serum Fatty Acids for the Prediction of Autoimmune Diseases
Dimitris Tsoukalas et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
T Cell Calcium Signaling Regulation by the Co-Receptor CD5
Claudia M. Tellez Freitas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
Ashley V. Menk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Marco B. Schaaf et al.
CELL DEATH & DISEASE (2018)
The role of endoplasmic reticulum-mitochondria contact sites in the control of glucose homeostasis: an update
Jennifer Rieusset
CELL DEATH & DISEASE (2018)
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
Muhammad Zubair Afzal et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
Tara C. Mitchell et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong-Ho Cha et al.
MOLECULAR CELL (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
GITR Agonism Enhances Cellular Metabolism to Support CD8+ T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model
Simran S. Sabharwal et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy
Ashley E. Mahne et al.
CANCER RESEARCH (2017)
4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation
Beom K. Choi et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Nicole E. Scharping et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Oxygen availability and metabolic reprogramming in cancer
Hong Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells
J. Feng et al.
ONCOGENE (2017)
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
Kenji Chamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
Mariangela Lecciso et al.
FRONTIERS IN IMMUNOLOGY (2017)
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
Arthur E. Frankel et al.
NEOPLASIA (2017)
Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells
Amir A. Al-Khami et al.
ONCOIMMUNOLOGY (2017)
GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory
Nick M. Durham et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Phase I study of BMS-663513, a fully human anti-CD137 agonist monoclonal antibody, in patients (pts) with advanced cancer (CA)
M. Sznol et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors
Anthony W. Tolcher et al.
CLINICAL CANCER RESEARCH (2017)
Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet
Danielle M. Lussier et al.
BMC CANCER (2016)
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Michael D. Buck et al.
CELL (2016)
Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy
Alfonso R. Sanchez-Paulete et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction (vol 45, pg 374, 2016)
Nicole E. Scharping et al.
IMMUNITY (2016)
CD28 Costimulation: From Mechanism to Therapy
Jonathan H. Esensten et al.
IMMUNITY (2016)
mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation
Hu Zeng et al.
IMMUNITY (2016)
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8+ T Cell Exhaustion
Bertram Bengsch et al.
IMMUNITY (2016)
Metabolomics in rheumatic diseases: desperately seeking biomarkers
Monica Guma et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Q. Qu et al.
CELL DEATH & DISEASE (2016)
ICOS Co-Stimulation: Friend or Foe?
Daniel J. Wikenheiser et al.
FRONTIERS IN IMMUNOLOGY (2016)
Suppressive effects of tumor cell-derived 5 '-deoxy-5 '-methylthioadenosine on human T cells
Frederik C. Henrich et al.
ONCOIMMUNOLOGY (2016)
ER-to-mitochondria miscommunication and metabolic diseases
Camila Lopez-Crisosto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
Aiden Haghikia et al.
IMMUNITY (2015)
Programmed Death-1 Controls T Cell Survival by Regulating Oxidative Metabolism
Victor Tkachev et al.
JOURNAL OF IMMUNOLOGY (2015)
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
Nikolaos Patsoukis et al.
NATURE COMMUNICATIONS (2015)
T-cell metabolism in autoimmune disease
Zhen Yang et al.
ARTHRITIS RESEARCH & THERAPY (2015)
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
Adipokines: A link between obesity and cardiovascular disease
Kazuto Nakamura et al.
JOURNAL OF CARDIOLOGY (2014)
Differential Impact of CD27 and 4-1BB Costimulation on Effector and Memory CD8 T Cell Generation following Peptide Immunization
Jane E. Willoughby et al.
JOURNAL OF IMMUNOLOGY (2014)
Targeting Th17 cells in autoimmune diseases
Jianfei Yang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih-Hao Chang et al.
CELL (2013)
WASH Knockout T Cells Demonstrate Defective Receptor Trafficking, Proliferation, and Effector Function
Joshua T. Piotrowski et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Metabolic regulation of organelle homeostasis in lupus T cells
Tiffany N. Caza et al.
CLINICAL IMMUNOLOGY (2012)
Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory Development
Gerritje J. W. van der Windt et al.
IMMUNITY (2012)
Network Analysis Reveals Centrally Connected Genes and Pathways Involved in CD8+ T Cell Exhaustion versus Memory
Travis A. Doering et al.
IMMUNITY (2012)
Metabolic Disturbances Associated with Systemic Lupus Erythematosus
Tianfu Wu et al.
PLOS ONE (2012)
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Semenza
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
Lewis Z. Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Adiposopathy Is Sick Fat a Cardiovascular Disease?
Harold E. Bays
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
Jean-Philippe Dales et al.
BMC MEDICINE (2010)
Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy
David Coe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)
Tyler R. Simpson et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Lipid accumulation and dendritic cell dysfunction in cancer
Donna L. Herber et al.
NATURE MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
E. John Wherry et al.
IMMUNITY (2007)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation
K Glunde et al.
CANCER RESEARCH (2005)
Hypoxia inducible factor 1α regulates T cell receptor signal transduction
AK Neumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Hypoxia modulates early events in T cell receptor-mediated activation in human T lymphocytes via Kv1.3 channels
JR Robbins et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
CD107a as a functional marker for the identification of natural killer cell activity
G Alter et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Control of Bcl-2 expression by reactive oxygen species
DA Hildeman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells
M Tone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hypoxia-inducible factors 1α and 2α are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin
A Giatromanolaki et al.
MELANOMA RESEARCH (2003)
Hypoxia regulates expression and activity of Kv1.3 channels in T lymphocytes: A possible role in T cell proliferation
L Conforti et al.
JOURNAL OF IMMUNOLOGY (2003)
CTLA-4-Ig regulates tryptophan catabolism in vivo
U Grohmann et al.
NATURE IMMUNOLOGY (2002)
The interaction properties of costimulatory molecules revisited
AV Collins et al.
IMMUNITY (2002)
The CD28 signaling pathway regulates glucose metabolism
KA Frauwirth et al.
IMMUNITY (2002)
Stimulation of CD25+CD4+regulatory T cells through GITR breaks immunological self-tolerance
J Shimizu et al.
NATURE IMMUNOLOGY (2002)
Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions
CC Caldwell et al.
JOURNAL OF IMMUNOLOGY (2001)
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
T Okazaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
H Nishimura et al.
SCIENCE (2001)
Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not T(H)2 cytokines
LP Kane et al.
NATURE IMMUNOLOGY (2001)
分享论文
